ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹262 Cr | ₹136 Cr | ₹144 Cr | ₹184 Cr | ₹190 Cr |
What is the latest Total Non-Current Liabilities ratio of ABBOTT INDIA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹262 Cr |
| Mar2024 | ₹136 Cr |
| Mar2023 | ₹144 Cr |
| Mar2022 | ₹184 Cr |
| Mar2021 | ₹190 Cr |
How is Total Non-Current Liabilities of ABBOTT INDIA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹262 Cr | 92.61 | |
| Mar2024 | ₹136 Cr | -5.55 | |
| Mar2023 | ₹144 Cr | -21.80 | |
| Mar2022 | ₹184 Cr | -2.87 | |
| Mar2021 | ₹190 Cr | - | |
Compare Total Non-Current Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹54,201.8 Cr | -0.1% | -4.5% | -19.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -0.1% |
-4.5% |
-19.3% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses